10 rapports clés pour analyser vos campagnes Emarketing avec la Hypertension
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II – therapy. The 2004 Canadian recommendations for the management of hypertension: part III-lifestyle modifications to prevent and control hypertension. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
75 years: a randomized clinical trial.
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. 75 years: a randomized clinical trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. A randomized trial of intensive versus standard blood pressure control. A clinical trial of the effects of dietary patterns on blood pressure. Careful monitoring should be used if combining an ACE inhibitor and an ARB because of potential adverse effects such as hypotension, hyperkalemia, and worsening renal function (Grade C). The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. Hypertension artérielle pulmonaire espérance de vie . Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis.
1.Patients with hypertension attributable to atherosclerotic renal artery stenosis should be primarily medically managed because renal angioplasty and stenting offers no benefit over optimal medical therapy alone (Grade B). 5.Renal artery angioplasty without stenting is recommended for treatment of FMD-related renal artery stenosis. 3.Patients with confirmed renal FMD should be referred to a hypertension specialist (Grade D; new guideline). 1.For most hypertensive patients with CAD, an ACE inhibitor or ARB is recommended (Grade A). 4.For hypertensive patients whose BP is not controlled, an ARB may be combined with an ACE inhibitor and other antihypertensive drug treatment (Grade A). Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. Three hundred and forty-eight women with a confirmed clinic blood pressure of at least 140/90 mm Hg were recruited. RESULTS: Three hundred and forty-eight women were recruited to the study. Design Prospective observational study. Design: Prospective observational study. STUDY DESIGN: A prospective, observational study was carried out in two large teaching hospitals.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. 0.008. No BP parameter at study entry permitted discrimination between those women with WCH who retained this phenomenon and those who developed GH or PE. Conclusion: WCH is a common phenomenon in pregnant women who appear to have EH according to routine BP measurement early in pregnancy. To assess the diagnosis and prognosis of white coat hypertension (WCH) as detected by home blood pressure (HBP) monitoring measured telemetrically in pregnant women with recently discovered hypertension. Objective: White coat hypertension (WCH) is a common phenomenon with a long term prognosis intermediate between those with true hypertension and true normotension. Objective White coat hypertension (WCH) is a common phenomenon with a long term prognosis intermediate between those with true hypertension and true normotension.
Conclusion WCH is a common phenomenon in pregnant women who appear to have EH according to routine BP measurement early in pregnancy. Objectives: To assess the diagnosis and prognosis of white coat hypertension (WCH) as detected by home blood pressure (HBP) monitoring measured telemetrically in pregnant women with recently discovered hypertension. Hypertension et diabete . Population Two hundred and forty-one pregnant women with an early pregnancy diagnosis of essential hypertension (EH). However, continued monitoring throughout pregnancy remains important to detect the small group of white coat hypertensives who develop PE. This author contributed to guideline development, provided comments to the manuscript, and approved the final manuscript. The corrected author and affiliation list appears below. Can J Cardiol 2017;33:557-576.), Karen C. Tran was omitted from the author list at the time of publication.